- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Moderate to Severe Atopic Eczema
Total 1644 results
-
Merz Aesthetics GmbHMerz Pharmaceuticals GmbHCompletedModerate to Severe Glabellar Frown LinesUnited States, Germany
-
Croma-Pharma GmbHActive, not recruitingModerate to Severe Midface Volume DeficitUnited States
-
Merz Pharmaceuticals GmbHCompletedModerate to Severe Glabellar Frown LinesUnited States
-
AllerganCompletedPatients With Moderate to Severe Perioral LinesUnited States
-
Xinhua Hospital, Shanghai Jiao Tong University...TerminatedASD Accompanied by Moderate to Severe Gastrointestinal SymptomsChina
-
Astellas Pharma Europe Ltd.CompletedModerate to Severe Vasomotor SymptomsUnited Kingdom
-
Astellas Pharma China, Inc.CompletedModerate/Severe Atopic DermatitisChina
-
Merz North America, Inc.CompletedCorrection of Moderate to Severe Nasolabial Folds (NLFs)China
-
Merz North America, Inc.CompletedCorrection of the Moderate to Severe Nasolabial FoldsChina
-
Kythera BiopharmaceuticalsCompletedEfficacy | Safety | Moderate to Severe Convexity of Submental FatUnited States
-
Kythera BiopharmaceuticalsCompletedEfficacy | Safety | Moderate to Severe Convexity of Submental FatUnited States
-
MEDA PHARMA SPA, a Viatris companyNot yet recruitingMild to Moderate Atopic Dermatitis
-
Creabilis SATerminated
-
Wake Forest University Health SciencesActive, not recruiting
-
Bitop AGCompletedMild to Moderate Atopic DermatitisGermany
-
HK inno.N CorporationNot yet recruiting
-
Greenpharma S.A.S.Complife Italia S.r.lCompletedMild to Moderate Atopic DermatitisItaly
-
HanAll BioPharma Co., Ltd.CompletedMild to Moderate Atopic DermatitisUnited States
-
BayerCompletedMild to Moderate Atopic DermatitisGermany
-
PfizerCompleted
-
QRxPharma Inc.CompletedAcute Moderate to Severe PainUnited States
-
Merz North America, Inc.CompletedCorrection of Moderate to Severe Nasolabial FoldsUnited States
-
Egalet LtdCompletedModerate-to-severe Chronic Noncancer PainUnited States
-
Merck Sharp & Dohme LLCTerminatedWomen | Moderate to Severe Vasomotor Symptoms in Postmenopausal
-
Janssen PharmaceuticaWithdrawnModerate to Severe Acute Non-Cancer Pain
-
KoBioLabsNovotech (Australia) Pty LimitedCompletedModerate to Severe AsthmaAustralia
-
AbbottCompletedModerate to Severe Chronic, Non-malignant PainUnited States
-
BioPharmX, Inc.CompletedModerate to Severe Papulopustular RosaceaUnited States
-
Janssen PharmaceuticaWithdrawnModerate to Severe Chronic Non-cancer Pain
-
Mundipharma Research GmbH & Co KGCompletedSubjects With Moderate to Severe, Chronic Nonmalignant Pain
-
Actavis Inc.CompletedModerate to Severe Papulopustular RosaceaUnited States
-
Wake Forest University Health SciencesCompleted
-
Merck KGaA, Darmstadt, GermanyCompletedModerate to Severe PsoriasisSwitzerland
-
Merck KGaA, Darmstadt, GermanyCompletedModerate to Severe PsoriasisSwitzerland
-
PfizerCompletedModerate to Severe PsoriasisKorea, Republic of
-
Shanghai Junshi Bioscience Co., Ltd.CompletedModerate to Severe PsoriasisChina
-
Bristol-Myers SquibbTerminatedPsoriasis, Moderate to SevereUnited States
-
GC Cell CorporationRecruitingClinical Trial to Evaluate the Safety, Tolerability and Efficacy of CT303 in Patients With PsoriasisModerate to Severe Plaque PsoriasisKorea, Republic of
-
UCB Biopharma SRLActive, not recruitingModerate to Severe Plaque PsoriasisUnited States, Canada, Germany, Poland
-
TakedaNimbus Lakshmi, Inc.; Innovaderm Research Inc.CompletedModerate to Severe Plaque PsoriasisUnited States, Canada
-
BiocadCompleted
-
AbbVieCompleted
-
AbbVie (prior sponsor, Abbott)CompletedModerate to Severe Plaque PsoriasisRussian Federation
-
Kyowa Kirin Co., Ltd.Completed
-
Suzhou Suncadia Biopharmaceuticals Co., Ltd.RecruitingModerate-to-Severe Plaque PsoriasisChina
-
Beijing InnoCare Pharma Tech Co., Ltd.RecruitingModerate to Severe Plaque PsoriasisChina
-
Jiangsu HengRui Medicine Co., Ltd.Not yet recruitingModerate-to-Severe Plaque Psoriasis
-
IpsenRecruitingModerate to Severe Upper Facial LinesGermany, France
-
Sun Pharmaceutical Industries LimitedRecruitingModerate to Severe Plaque PsoriasisUnited States, El Salvador
-
Suzhou Zelgen Biopharmaceuticals Co.,LtdActive, not recruitingModerate-to-Severe Plaque PsoriasisChina